Axcelis Technologies, Inc. (NASDAQ:ACLS) Receives Average Rating of “Hold” from Analysts

Shares of Axcelis Technologies, Inc. (NASDAQ:ACLSGet Free Report) have been given a consensus rating of “Hold” by the seven analysts that are covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $132.20.

Several analysts have issued reports on ACLS shares. Bank of America raised their price objective on shares of Axcelis Technologies from $130.00 to $156.00 and gave the stock an “underperform” rating in a research note on Tuesday, June 23rd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axcelis Technologies in a research note on Friday, August 7th. Finally, Craig Hallum downgraded Axcelis Technologies from a “buy” rating to a “hold” rating and set a $140.00 price target on the stock. in a report on Friday, August 7th.

View Our Latest Report on ACLS

Axcelis Technologies Trading Down 1.2%

ACLS stock opened at $103.75 on Thursday. The company has a quick ratio of 3.21, a current ratio of 4.90 and a debt-to-equity ratio of 0.04. Axcelis Technologies has a twelve month low of $73.60 and a twelve month high of $193.78. The stock has a market capitalization of $3.20 billion, a price-to-earnings ratio of 34.82, a price-to-earnings-growth ratio of 3.21 and a beta of 1.86. The firm’s fifty day simple moving average is $127.79 and its two-hundred day simple moving average is $131.27.

Axcelis Technologies (NASDAQ:ACLSGet Free Report) last released its earnings results on Thursday, August 6th. The semiconductor company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.17. Axcelis Technologies had a net margin of 10.71% and a return on equity of 11.69%. The firm had revenue of $215.18 million during the quarter, compared to analyst estimates of $205.03 million. During the same quarter last year, the business earned $1.13 EPS. The business’s revenue was up 10.6% on a year-over-year basis. Axcelis Technologies has set its Q3 2026 guidance at 1.110-1.110 EPS. As a group, analysts anticipate that Axcelis Technologies will post 3.39 earnings per share for the current year.

Hedge Funds Weigh In On Axcelis Technologies

Several hedge funds have recently bought and sold shares of ACLS. Dimensional Fund Advisors LP boosted its stake in shares of Axcelis Technologies by 0.4% during the first quarter. Dimensional Fund Advisors LP now owns 844,097 shares of the semiconductor company’s stock valued at $78,565,000 after purchasing an additional 3,057 shares during the period. The Manufacturers Life Insurance Company lifted its holdings in Axcelis Technologies by 3,402.5% during the 1st quarter. The Manufacturers Life Insurance Company now owns 491,745 shares of the semiconductor company’s stock valued at $45,772,000 after buying an additional 477,705 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Axcelis Technologies by 1.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 431,195 shares of the semiconductor company’s stock valued at $34,642,000 after buying an additional 4,082 shares in the last quarter. LSV Asset Management lifted its holdings in Axcelis Technologies by 36.4% during the 4th quarter. LSV Asset Management now owns 429,500 shares of the semiconductor company’s stock valued at $34,506,000 after buying an additional 114,600 shares in the last quarter. Finally, UBS Group AG boosted its position in Axcelis Technologies by 67.6% in the 4th quarter. UBS Group AG now owns 213,388 shares of the semiconductor company’s stock valued at $17,144,000 after buying an additional 86,065 shares during the period. Institutional investors own 89.98% of the company’s stock.

Axcelis Technologies Company Profile

(Get Free Report)

Axcelis Technologies, Inc is a semiconductor equipment company that designs, manufactures and services ion implantation systems used in the production of semiconductor devices. Its equipment modifies the electrical properties of silicon wafers by implanting precisely controlled ions, an important step in manufacturing power semiconductors, memory products and other integrated circuits.

The company’s primary product family is the Purion platform, which includes systems designed for high-current, medium-current and high-energy implantation applications.

Read More

Analyst Recommendations for Axcelis Technologies (NASDAQ:ACLS)

Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.